ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 83 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $141,000 | -66.1% | 40,315 | -4.5% | 0.01% | -70.0% |
| Q1 2021 | $416,000 | -15.4% | 42,215 | -7.1% | 0.03% | -9.1% |
| Q4 2020 | $492,000 | -69.1% | 45,433 | -67.1% | 0.03% | -66.3% |
| Q4 2019 | $1,592,000 | +68.1% | 138,200 | -11.7% | 0.10% | +151.3% |
| Q3 2018 | $947,000 | -14.8% | 156,500 | -25.3% | 0.04% | -7.1% |
| Q2 2018 | $1,111,000 | -50.3% | 209,598 | -45.7% | 0.04% | -44.0% |
| Q1 2018 | $2,237,000 | +2305.4% | 385,700 | +1016.5% | 0.08% | +1400.0% |
| Q1 2017 | $93,000 | -7.0% | 34,546 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $100,000 | -39.4% | 34,546 | -14.2% | 0.01% | -30.0% |
| Q3 2016 | $165,000 | +12.2% | 40,246 | -13.7% | 0.01% | -16.7% |
| Q2 2016 | $147,000 | – | 46,646 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |